Synonym
AH078; AH-078; AH 078
IUPAC/Chemical Name
(2R,4S)-1-((R)-2-(8-(4-fluoro-4-((4-(5-fluoropyridin-2-yl)-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)-1H-imidazol-1-yl)methyl)piperidin-1-yl)-8-oxooctanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide
InChi Key
PWYJKWQDDHJXMJ-JMVXIWCISA-N
InChi Code
InChI=1S/C51H60F2N10O5S/c1-32-45(69-31-59-32)34-13-11-33(12-14-34)26-57-48(67)40-25-36(64)28-63(40)49(68)46(50(2,3)4)60-41(65)9-7-5-6-8-10-42(66)61-23-19-51(53,20-24-61)29-62-30-58-43(39-16-15-35(52)27-56-39)44(62)37-17-21-54-47-38(37)18-22-55-47/h11-18,21-22,27,30-31,36,40,46,64H,5-10,19-20,23-26,28-29H2,1-4H3,(H,54,55)(H,57,67)(H,60,65)/t36-,40+,46-/m0/s1
SMILES Code
FC1=CN=C(C2=C(C3=C(C=CN4)C4=NC=C3)N(CC5(CCN(C(CCCCCCC(N[C@H](C(C)(C)C)C(N6C[C@@H](O)C[C@@H]6C(NCC7=CC=C(C8=C(C)N=CS8)C=C7)=O)=O)=O)=O)CC5)F)C=N2)C=C1
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
963.16
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Haag A, Němec V, Janovská P, Bartošíková J, Adhikari B, Müller J, Schwalm MP,
Čada Š, Ohmayer U, Daub H, Kim Y, Born F, Wolf E, Bryja V, Knapp S. Development
and Discovery of a Selective Degrader of Casein Kinases 1 δ/ε. J Med Chem. 2024
Dec 27. doi: 10.1021/acs.jmedchem.4c02201. Epub ahead of print. PMID: 39729064.
2: Wills RH, Habtemariam A, Lopez-Clavijo AF, Barrow MP, Sadler PJ, O'Connor PB.
Insights into the binding sites of organometallic ruthenium anticancer compounds
on peptides using ultra-high resolution mass spectrometry. J Am Soc Mass
Spectrom. 2014 Apr;25(4):662-72. doi: 10.1007/s13361-013-0819-2. Epub 2014 Feb
1. PMID: 24488754.